The structures of prostaglandin endoperoxide H synthases-1 and -2.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Prostaglandins & other lipid mediators

• Publication date

  2002-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0090-6980(02)00026-6PMID 12432914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of Prostaglandin Stereochemistry at the 15-Carbon by Cyclooxygenases-1 and -2

  2002cited by this paper
• Biochemistry of Lipids, Lipoproteins and Membranes

  2002cited by this paper
• Structure of Eicosapentaenoic and Linoleic Acids in the Cyclooxygenase Site of Prostaglandin Endoperoxide H Synthase-1*

  2001cited by this paper
• Prostaglandin Endoperoxide H Synthase-1

  2001cited by this paper
• Mutational and X-ray Crystallographic Analysis of the Interaction of Dihomo-γ-linolenic Acid with Prostaglandin Endoperoxide H Synthases*

  2001cited by this paper
• A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors.

  2001cited by this paper
• Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations.

  2001cited by this paper
• Structural insights into the stereochemistry of the cyclooxygenase reaction

  2000cited by this paper
• Different Catalytically Competent Arrangements of Arachidonic Acid within the Cyclooxygenase Active Site of Prostaglandin Endoperoxide H Synthase-1 Lead to the Formation of Different Oxygenated Products*

  2000cited by this paper
• Anchoring of a monotopic membrane protein: the binding of prostaglandin H2 synthase-1 to the surface of a phospholipid bilayer

  2000cited by this paper
• Cyclooxygenase mechanisms.

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• Stereospecificity of Hydrogen Abstraction in the Conversion of Arachidonic Acid to 15R-HETE by Aspirin-treated Cyclooxygenase-2

  2000cited by this paper
• Purification and characterization of the human recombinant histidine-tagged prostaglandin endoperoxide H synthases-1 and -2.

  2000cited by this paper
• The productive conformation of arachidonic acid bound to prostaglandin synthase.

  2000cited by this paper
• The formation of stable fatty acid substrate complexes in prostaglandin H(2) synthase-1.

  2000cited by this paper
• Peroxidase activity in prostaglandin endoperoxide H synthase-1 occurs with a neutral histidine proximal heme ligand.

  2000cited by this paper
• Basic biology and clinical application of specific cyclooxygenase-2 inhibitors.

  2000cited by this paper
• The Membrane Binding Domains of Prostaglandin Endoperoxide H Synthases 1 and 2

  1999cited by this paper
• Inflammation of the brain in Alzheimer's disease: implications for therapy

  1999cited by this paper
• Arachidonic Acid Oxygenation by COX-1 and COX-2

  1999cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• The Role of Arginine 120 of Human Prostaglandin Endoperoxide H Synthase-2 in the Interaction with Fatty Acid Substrates and Inhibitors*

  1999cited by this paper
• The Binding of Arachidonic Acid in the Cyclooxygenase Active Site of Mouse Prostaglandin Endoperoxide Synthase-2 (COX-2)

  1999cited by this paper
• The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins.

  1999cited by this paper
• Cox-2-selective inhibitors: the new super aspirins.

  1999cited by this paper
• Comparison of prostaglandin H synthase-1 and -2 structural stabilities.

  1999cited by this paper
• Cyclooxygenase-1 and -2 isoenzymes.

  1999cited by this paper
• Comparison of Structural Stabilities of Prostaglandin H Synthase-1 and -2*

  1998cited by this paper
• The Membrane Association Sequences of the Prostaglandin Endoperoxide Synthases-1 and -2 Isozymes*

  1998cited by this paper
• Structural Characterization of Arachidonyl Radicals Formed by Prostaglandin H Synthase-2 and Prostaglandin H Synthase-1 Reconstituted with Mangano Protoporphyrin IX*

  1998cited by this paper
• The Dynamics of Prostaglandin H Synthases

  1998cited by this paper
• Comparison of Peroxidase Reaction Mechanisms of Prostaglandin H Synthase-1 Containing Heme and Mangano Protoporphyrin IX*

  1997cited by this paper
• The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.

  1997cited by this paper
• Conversion of Prostaglandin G/H Synthase-1 into an Enzyme Sensitive to PGHS-2-selective Inhibitors by a Double His513 → Arg and Ile523 → Val Mutation*

  1997cited by this paper
• Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2.

  1997cited by this paper
• Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer

  1997cited by this paper
• Mutational Analysis of the Role of the Distal Histidine and Glutamine Residues of Prostaglandin-Endoperoxide Synthase-2 in Peroxidase Catalysis, Hydroperoxide Reduction, and Cyclooxygenase Activation*

  1997cited by this paper
• Crystal structure of horseradish peroxidase C at 2.15 Å resolution

  1997cited by this paper
• C-terminal Ser/Pro-Thr-Glu-Leu tetrapeptides of prostaglandin endoperoxide H synthases-1 and -2 target the enzymes to the endoplasmic reticulum.

  1996cited by this paper
• Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site.

  1996cited by this paper
• On the function of neuromelanin

  1996cited by this paper
• On the functional of neuromelanin.

  1996cited by this paper
• Involvement of Arginine 120, Glutamate 524, and Tyrosine 355 in the Binding of Arachidonate and 2-Phenylpropionic Acid Inhibitors to the Cyclooxygenase Active Site of Ovine Prostaglandin Endoperoxide H Synthase-1 (*)

  1996cited by this paper
• Prostaglandin endoperoxide H synthases-1 and -2.

  1996cited by this paper
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1996cited by this paper
• Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site (*)

  1996cited by this paper
• Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

  1996cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Role of Val509 in Time-dependent Inhibition of Human Prostaglandin H Synthase-2 Cyclooxygenase Activity by Isoform-selective Agents*

  1996cited by this paper
• Prostaglandin synthase 2.

  1996cited by this paper
• A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors*

  1996cited by this paper
• Turning down the heat: new routes to inhibition of inflammatory signaling by prostaglandin H2 synthases.

  1995cited by this paper
• The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

  1995cited by this paper
• Arginine 120 of Prostaglandin G/H Synthase-1 Is Required for the Inhibition by Nonsteroidal Anti-inflammatory Drugs Containing a Carboxylic Acid Moiety *

  1995cited by this paper
• Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase.

  1995cited by this paper
• Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2

  1995cited by this paper
• Different Intracellular Locations for Prostaglandin Endoperoxide H Synthase-1 and −2 (*)

  1995cited by this paper
• Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.

  1994cited by this paper
• Mutation of serine‐516 in human prostaglandin G/H synthase‐2 to methionine or aspirin acetylation of this residue stimulates 15‐R‐HETE synthesis

  1994cited by this paper
• The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

  1994cited by this paper
• Raster3D Version 2.0. A program for photorealistic molecular graphics.

  1994cited by this paper
• Prostaglandin H synthase: Implications for membrane structure

  1994cited by this paper
• Prostaglandin H synthase

  1994cited by this paper
• Aspirin as an antiplatelet drug.

  1994cited by this paper
• Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.

  1994cited by this paper
• Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system.

  1994cited by this paper
• N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum.

  1993cited by this paper
• Epidermal growth factor-like modules

  1993cited by this paper
• SETOR: hardware-lighted three-dimensional solid model representations of macromolecules.

  1993cited by this paper
• X-ray crystal structure of canine myeloperoxidase at 3 A resolution.

  1992cited by this paper
• Prostaglandin endoperoxide synthase. The aspirin acetylation region.

  1992cited by this paper
• Essential histidines of prostaglandin endoperoxide synthase. His-309 is involved in heme binding.

  1991cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991cited by this paper
• Metal-ligand vibrations of cyanoferric myeloperoxidase and cyanoferric horseradish peroxidase: evidence for a constrained heme pocket in myeloperoxidase.

  1990cited by this paper
• The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.

  1990cited by this paper
• Controlled tryptic digestion of prostaglandin H synthase. Characterization of protein fragments and enhanced rate of proteolysis of oxidatively inactivated enzyme.

  1987cited by this paper
• Prostaglandins and related substances : a practical approach

  1987cited by this paper
• Protection of prostaglandin H synthase from trypsin upon binding of heme.

  1982cited by this paper
• Prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. Inactivation and activation by heme and other metalloporphyrins.

  1978cited by this paper
• Purification and characterisation of prostaglandin endoperoxide synthetase from sheep vesicular glands.

  1977cited by this paper
• Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs.

  1975cited by this paper
• On the mechanism of the biosynthesis of prostaglandins E-1 and F-1-alpha.

  1967cited by this paper

• Design, synthesis, biological evaluation and computational studies of novel phthalimides as dual COX-2/5-LOX inhibitors.

  2026cites this paper
• Therapeutic Role of Cyclooxygenase-1 (COX-1) Inhibition, Challenging the Conventional View of COX-1 as Purely Constitutive.

  2026cites this paper
• Synthesis, X-ray Crystallography, and Computational Analysis of 2,4-disubstituted-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidines as COX-2 Inhibitors and Anticancer Agents

  2025cites this paper
• Expression Profiling and Functional Role of Cyclooxygenase-2 in the Immune and Inflammatory Responses of Red-spotted Grouper (Epinephelus akaara).

  2025cites this paper
• Design and synthesis of new 1,3,4-oxadiazole-1,2,3,4-tetrahydroisoquinoline hybrids as selective COX-2 inhibitors.

  2025cites this paper
• Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof

  2024cites this paper
• Targeting inflammation through inhibition of COX-2 by substituted 4-thiazolidinone analogues: in-vitro, in-vivo and in-silico studies

  2024cites this paper
• Laboratory‐scale preparation of prostaglandins using acetone powder of the red alga Gracilaria vermiculophylla

  2024cites this paper
• Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition

  2024cites this paper
• Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis

  2023cites this paper
• Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective

  2023cites this paper
• Methanesulfonamide derivatives as gastric safe anti-inflammatory agents: Design, synthesis, selective COX-2 inhibitory activity, histopathological and histochemical studies.

  2023cites this paper
• Acetylsalicylic Acid–Primus Inter Pares in Pharmacology

  2022cites this paper
• Novel Therapeutic Heterocycles as Selective Cyclooxygenase-2 Inhibitors and Anti-Cancer Agents: Synthesis, In Vitro Bioassay Screenings, and Molecular Docking Studies

  2022cites this paper
• Molecular Docking and Study of the Anti-inflammatory Effect of Triterpene and Diarylheptanoid Isolated from Pellacalyx axillaris.

  2022cites this paper
• Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing

  2022cites this paper
• Analysis of Sex-Specific Prostanoid Production Using a Mouse Model of Selective Cyclooxygenase-2 Inhibition

  2022cites this paper
• Construction of Phylogenetic Tree for Cyclooxygenase Dataset by Clustering

  2021cites this paper
• In vitro evaluation and molecular docking analysis of potential anticancer compounds from Annona muricata L.

  2021cites this paper
• Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro

  2021cites this paper
• Cyclooxygenases and the cardiovascular system.

  2020cites this paper
• The Biosynthesis of Enzymatically Oxidized Lipids

  2020cites this paper
• COX-2 Signaling in the Tumor Microenvironment.

  2020cites this paper
• Investigation of host-guest interactions between polyester dendrimers and ibuprofen using density functional theory (DFT)

  2020cites this paper
• Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches

  2020cites this paper
• Biomolecular docking, synthesis, crystal structure, and bioassay studies of 1-[4-(2-chloroethoxy)phenyl]-5-[4-(methylsulfonyl)phenyl]-1H-tetrazole and 2-(4-(5-(4-(methylsulfonyl)phenyl)-1H-tetrazol-1-yl)phenoxy)ethyl nitrate

  2020cites this paper
• Eicosanoid biosynthesis in marine mammals

  2020cites this paper
• Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies.

  2020cites this paper
• Applications and Limitations of Dendrimers in Biomedicine

  2020cites this paper
• In silico characterisation of olive phenolic compounds as potential cyclooxygenase modulators. Part 1.

  2020cites this paper
• In silico characterisation of olive phenolic compounds as potential cyclooxygenase modulators. Part 2.

  2020cites this paper
• Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: A review.

  2020cites this paper
• Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

  2020cites this paper
• COX-1 – lipid interactions: arachidonic acid, cholesterol, and phospholipid binding to the membrane binding domain of COX-1

  2020cites this paper
• The phytochemical and anti‐inflammatory studies of Dillenia suffruticosa leaves

  2019cites this paper
• Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008-2019).

  2019cites this paper
• Free radical-dependent inhibition of prostaglandin endoperoxide H Synthase-2 by nitro-arachidonic acid.

  2019cites this paper
• Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

  2019cites this paper
• Alternations of Metabolic Profiles in Synovial Fluids and the Correlation with T2 Relaxation Times of Cartilage and Meniscus—A Study on Anterior Cruciate Ligament- (ACL-) Injured Rabbit Knees at Early Stage

  2019cites this paper
• A New Look at the Structures of Old Sepsis Actors by Exploratory Data Analysis Tools

  2019influential citation
• Chapter 13 Drosophila : A Model for Studying Prostaglandin Signaling

  2018cites this paper
• Raging the War Against Inflammation With Natural Products

  2018cites this paper
• Effect of Polyphenols From Campomanesia adamantium on Platelet Aggregation and Inhibition of Cyclooxygenases: Molecular Docking and in Vitro Analysis

  2018cites this paper
• Biophysical insights into dietary antioxidants as cyclooxygenase modulators

  2018influential citation
• Unexpected formation of 1-[4-chloromethylphenyl]-5-[4-(methylsulfonyl)benzyl]-1 H -tetrazole and 1-[4-chloromethylphenyl]-5-[4-(aminosulfonyl)phenyl]-1 H -tetrazole: Crystal structure, bioassay screening and molecular docking studies

  2018cites this paper
• Single nucleotide polymorphism rs4648298 in miRNAs hsa-miR21 and hsa-miR590 binding site of COX gene is a strong colorectal cancer determinant.

  2018cites this paper
• Design, synthesis, and evaluation of novel 2-phenylpropionic acid derivatives as dual COX inhibitory-antibacterial agents

  2017cites this paper
• Synthesis, Characterization, and Nanomedical Applications of Conjugates between Resorcinarene-Dendrimers and Ibuprofen

  2017cites this paper
• Molecular Basis of Binding Interactions of NSAIDs and Computer-Aided Drug Design Approaches in the Pursuit of the Development of Cyclooxygenase-2 (COX-2) Selective Inhibitors

  2017cites this paper
• Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit*

  2016cites this paper
• Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.

  2016cites this paper
• Synthesis and crystal structure of N-[(dimethylamino)methylidene]-4-[1-(4-nitrophenyl)-1H-tetrazol-5-yl]-benzenesulfonamide: Molecular docking and bioassay studies as cyclooxygenase-2 inhibitor

  2016cites this paper
• Structural and release properties of amylose inclusion complexes with ibuprofen

  2016cites this paper
• Synthesis of Novel Substituted Thiourea and Benzimidazole Derivatives Containing a Pyrazolone Ring as Anti‐Inflammatory Agents

  2016cites this paper
• Crystal structure of rofecoxib bound to human cyclooxygenase-2.

  2016cites this paper
• Structure-activity relationship of novel series of 1,5-disubstituted tetrazoles as cyclooxygenase-2 inhibitors: Design, synthesis, bioassay screening and molecular docking studies.

  2016cites this paper
• A Review on Pyridazinone Compounds ABT-963 as Selective CyclooxygenaseInhibitor

  2016cites this paper
• Repair Mechanisms in Oxidant-Driven Chronic Inflammatory Disease.

  2016cites this paper
• Reenacting of Phylogenetic Tree for Cyclooxygenase DNA Sequences by using MUSCLE

  2016cites this paper
• Structural and functional characterisation of dioxolane A3, a new eicosanoid generated by cycooxygenase-1 in platelets

  2016cites this paper
• Synthesis and in silico investigation of thiazoles bearing pyrazoles derivatives as anti-inflammatory agents

  2016cites this paper
• REGULATION OF MICROENVIRONMENT WITHIN THE OVIDUCT September , 2016

  2016influential citation
• Regulation of micro-environment within the oviduct

  2016cites this paper
• Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs

  2015cites this paper
• Chapter 42 – Parturition

  2015cites this paper
• Prostaglandin Synthesis in Marine Arthropods and Red Algae. Prostaglandiinide süntees mere lülijalgsetes ja punavetikates

  2015cites this paper
• Docking studies and the crystal structure of two tetrazole derivatives: 5-(4-chlorophenyl)-1-{4-(methylsulfonyl)phenyl}-1H-tetrazole and 4-{5-(4-methoxyphenyl)-1H-tetrazol-1-yl}benzenesulfonamide

  2015cites this paper
• A New Bi-Functional Derivative of Polyethylene Glycol as Molecular Carrier for Eugenol and Ibuprofen

  2015cites this paper
• Drosophila : A Model for Studying Prostaglandin Signaling

  2015cites this paper
• Opioids and Nonsteroidal Anti‐Inflammatory Drugs

  2015cites this paper
• Evaluating COX-2-765 G →C Genetic Polymorphism in Migraineurs

  2015cites this paper
• Synthesis, bioassay studies, and molecular docking of novel 5-substituted 1H tetrazoles as cyclooxygenase-2 (COX-2) inhibitors

  2014cites this paper
• 3D QSAR studies based in silico screening of 4,5,6-triphenyl-1,2,3,4-tetrahydropyrimidine analogs for anti-inflammatory activity.

  2014cites this paper
• Prostaglandin signaling temporally regulates actin cytoskeletal remodeling during drosophila oogenesis

  2014influential citation
• Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs.

  2014cites this paper
• Constructing of Phylogenetic Tree for COX based on sequences by using ClustalW

  2014cites this paper
• PROTEIN STRUCTURE REPORT Crystal structures of a-dioxygenase from Oryza sativa: Insights into substrate binding and activation by hydrogen peroxide

  2013cites this paper
• Thematic Review Series: Fat-Soluble Vitamins: Vitamin A Enzymology of retinoic acid biosynthesis and degradation

  2013cites this paper
• Enzymology of retinoic acid biosynthesis and degradation

  2013cites this paper
• The crystal structure of α-Dioxygenase provides insight into diversity in the cyclooxygenase-peroxidase superfamily.

  2013cites this paper
• Summer heat stress affects prostaglandin synthesis in the bovine oviduct.

  2013influential citation
• Discovery of Novel Fatty Acid Dioxygenases and Cytochromes P450 : Mechanisms of Oxylipin Biosynthesis in Pathogenic Fungi

  2013influential citation
• The role of prostaglandin E2 in human vascular inflammation.

  2013cites this paper
• The role of prostaglandin E 2 in human vascular in fl ammation

  2013cites this paper
• Eicosanoids and Renal Function

  2013cites this paper
• Hydroxamic Acids: An Important Class of Metalloenzyme Inhibitors

  2013cites this paper
• Investigating Substrate Promiscuity in Cyclooxygenase-2

  2012cites this paper
• Synthesis and evaluation of mutual prodrugs of ibuprofen with menthol, thymol and eugenol.

  2012cites this paper
• Molecular Mechanisms Regulating the Vascular Prostacyclin Pathways and Their Adaptation during Pregnancy and in the Newborn

  2012cites this paper
• Effects of DP and CRTH2 activation on osteoblast function

  2011cites this paper
• Cyclooxygenase-2 inhibitors: a literature and patent review (2009 – 2010)

  2011cites this paper
• The structure of NS-398 bound to cyclooxygenase-2.

  2011cites this paper
• Cyclooxygenase metabolites in the kidney.

  2011cites this paper
• NEW INSIGHTS INTO CYCLOOXYGENASE ISOFORMS AND CANCER TREATMENT: CYCLOOXYGENASE-2 INHIBITION - A PROMISING STRATEGY

  2011cites this paper
• Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships

  2011cites this paper
• The Structural Basis of Endocannabinoid Oxygenation by Cyclooxygenase-2*

  2011cites this paper
• Arachidonic Acid Metabolites and the Kidney

  2011cites this paper
• Cyclooxygenase-2 in oncogenesis.

  2011cites this paper
• Emerging role of cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions.

  2010cites this paper
• Estrogens disrupt serotonin receptor and cyclooxygenase mRNA expression in the gonads of mussels (Mytilus edulis).

  2010cites this paper